Manuel Rieber
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Immunology and Allergy top 10%
- Cell Adhesion Molecules Research
Papers in
-
- RNA Interference and Gene Delivery 10
- Cell death mechanisms and regulation 6
- Glycosylation and Glycoproteins Research 6
- Oncology 28
- Cancer-related Molecular Pathways 21
- Co-authors
- M. Rieber (44 shared papers)Ana M. Mendes‐Pereira (1 shared paper)T Imaeda (4 shared papers)Roberto A. Sánchez‐Delgado (1 shared paper)Egidio Romano (1 shared paper)Atilio Anzellotti (1 shared paper)Renée Lira (3 shared papers)J. D. Medina (2 shared papers)
- Journals
- International Journal of Cancer (15 papers)Biochemical and Biophysical Research Communications (13 papers)Biochemical Pharmacology (5 papers)Cancer Biology & Therapy (5 papers)DNA and Cell Biology (3 papers)
- Partner nations
- VenezuelaUnited StatesIreland
In The Last Decade
Manuel Rieber
71 papers receiving 752 citations
Peers
Comparison fields: 5 of 90
- Cancer Research 178
- Immunology and Allergy 60
- Oncology 247
- Molecular Biology 479
- Biotechnology 58
Countries citing papers authored by Manuel Rieber
This map shows the geographic impact of Manuel Rieber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Rieber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Rieber more than expected).
Fields of papers citing papers by Manuel Rieber
This network shows the impact of papers produced by Manuel Rieber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Rieber. The network helps show where Manuel Rieber may publish in the future.
Co-authors
The 18 scholars most cited alongside Manuel Rieber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 41 | |
| 2 | 2005 | 41 | |
| 3 | 1998 | 41 | |
| 4 | 1981 | 41 | |
| 5 | 2005 | 34 | |
| 6 | 2003 | 27 | |
| 7 | 2012 | 26 | |
| 8 | 2004 | 25 | |
| 9 | 2015 | 24 | |
| 10 | 2020 | 24 | |
| 11 | 2006 | 22 | |
| 12 | 2000 | 21 | |
| 13 | 2009 | 20 | |
| 14 | 1974 | 20 | |
| 15 | 1989 | 17 | |
| 16 | 2014 | 16 | |
| 17 | 2011 | 15 | |
| 18 | Cyclin-dependent kinase 2 and cyclin A interaction with E2F are targets for tyrosine induction of B16 melanoma terminal differentiation. | 1994 | 15 |
| 19 | 2007 | 14 | |
| 20 | 2003 | 14 |
About Manuel Rieber
Manuel Rieber is a scholar working on Molecular Biology, Oncology, Cell Biology, Cancer Research and Immunology and Allergy, having authored 75 papers that have together received 785 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (21 papers), Cell Adhesion Molecules Research (11 papers), RNA Interference and Gene Delivery (10 papers), Cancer Research and Treatments (9 papers), Monoclonal and Polyclonal Antibodies Research (7 papers), melanin and skin pigmentation (6 papers), Cell death mechanisms and regulation (6 papers) and Glycosylation and Glycoproteins Research (6 papers). The work is most often cited by research in Cancer Research (178 citations), Immunology and Allergy (60 citations), Oncology (247 citations), Molecular Biology (479 citations) and Biotechnology (58 citations). Manuel Rieber has collaborated with scholars based in Venezuela, United States and Ireland. Frequent co-authors include M. Rieber, Ana M. Mendes‐Pereira, T Imaeda, Roberto A. Sánchez‐Delgado, Egidio Romano, Atilio Anzellotti, Renée Lira, J. D. Medina, Luis Alberto Gómez and Francisco Javier Martín Gil. Their work appears in journals such as International Journal of Cancer, Biochemical and Biophysical Research Communications, Biochemical Pharmacology, Cancer Biology & Therapy and DNA and Cell Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.